Alfred S L Cheng

Summary

Affiliation: The Chinese University of Hong Kong
Country: China

Publications

  1. ncbi Epigenetic Deregulation of MicroRNAs: New Opportunities to Target Oncogenic Signaling Pathways in Hepatocellular Carcinoma
    Zhuo Yu
    Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong SAR, PR China
    Curr Pharm Des 19:1192-200. 2013
  2. ncbi Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis
    Alfred S L Cheng
    Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China
    Gastroenterology 144:122-133.e9. 2013
  3. ncbi An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules
    Huaxia Qin
    Human Cancer Genetics Program, Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA
    BMC Syst Biol 3:73. 2009
  4. ncbi Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells
    Alfred S L Cheng
    Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, P R China
    Int J Oncol 23:113-9. 2003
  5. ncbi EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis
    Alfred S L Cheng
    Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China
    Cancer Res 71:4028-39. 2011
  6. ncbi Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma
    Alfred S L Cheng
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Int J Oncol 24:853-60. 2004
  7. ncbi Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice
    Jun Yu
    Institute of Digestive Disease and Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong, China
    Biochem Biophys Res Commun 372:571-7. 2008
  8. ncbi Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells
    Michael W Y Chan
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, PR China
    Oncol Rep 18:1557-62. 2007
  9. ncbi Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer
    Wei Kang
    Department of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Sir Y K Pao Center for Cancer, The Chinese University of Hong Kong, Hong Kong, China
    PLoS ONE 7:e33919. 2012
  10. ncbi Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer
    Kin Fai Cheung
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong
    Cancer 118:947-59. 2012

Collaborators

Detail Information

Publications23

  1. ncbi Epigenetic Deregulation of MicroRNAs: New Opportunities to Target Oncogenic Signaling Pathways in Hepatocellular Carcinoma
    Zhuo Yu
    Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong SAR, PR China
    Curr Pharm Des 19:1192-200. 2013
    ..Better understanding of the epigenetics-miRNA regulatory cascades in the control of the functionally significant pathways will provide new opportunities for the development of more effective therapeutic modality for HCC...
  2. ncbi Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis
    Alfred S L Cheng
    Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China
    Gastroenterology 144:122-133.e9. 2013
    ..Promoter hypermethylation occurs during Helicobacter pylori-induced gastritis. We investigated whether the deregulated genes contribute to gastric tumorigenesis...
  3. ncbi An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules
    Huaxia Qin
    Human Cancer Genetics Program, Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA
    BMC Syst Biol 3:73. 2009
    ..The regulatory effect of SMAD complex likely depends on transcriptional modules, in which the SMAD binding elements and partner transcription factor binding sites (SMAD modules) are present in specific context...
  4. ncbi Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells
    Alfred S L Cheng
    Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, P R China
    Int J Oncol 23:113-9. 2003
    ..In conclusion, specific COX-2 inhibitor suppresses cell proliferation and induces apoptosis in HCC cell lines that express COX-2. Our finding suggests that COX-2 inhibition may offer a new approach for HCC chemoprevention...
  5. ncbi EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis
    Alfred S L Cheng
    Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China
    Cancer Res 71:4028-39. 2011
    ....
  6. ncbi Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma
    Alfred S L Cheng
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Int J Oncol 24:853-60. 2004
    ..Moreover, COX-2 up-regulates VEGF expression in HCC cells, possibly via PGs production. Selective inhibition of COX-2 may block HCC associated angiogenesis and thus provides a rational approach for treatment of this malignancy...
  7. ncbi Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice
    Jun Yu
    Institute of Digestive Disease and Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong, China
    Biochem Biophys Res Commun 372:571-7. 2008
    ..This is the first report on the effect of COX-2 in liver fibrosis based on genetic mouse models. The results suggest that COX-2 does not appear to mediate the development of liver fibrosis...
  8. ncbi Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells
    Michael W Y Chan
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, PR China
    Oncol Rep 18:1557-62. 2007
    ..RNA interference may be a promising alternative to specific COX-2 inhibitors in the prevention and treatment of gastric cancer...
  9. ncbi Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer
    Wei Kang
    Department of Anatomical and Cellular Pathology, State Key Laboratory in Oncology in South China, Sir Y K Pao Center for Cancer, The Chinese University of Hong Kong, Hong Kong, China
    PLoS ONE 7:e33919. 2012
    ..Our findings supported an oncogenic role of STMN1 in gastric cancer. STMN1 might serve as a prognostic marker and a potential therapeutic target for gastric cancer...
  10. ncbi Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer
    Kin Fai Cheung
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong
    Cancer 118:947-59. 2012
    ..By using genome-wide methylation screening, the authors identified ring finger protein 180 (RNF180) as preferentially methylated in cancer. This study was undertaken to clarify its structure and functional role in gastric cancer...
  11. ncbi Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice
    Wai K Leung
    Institute of Digestive Disease and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China
    Carcinogenesis 29:1648-54. 2008
    ..In conclusion, both high salt and COX-2 overexpression promote chemical-induced gastric carcinogenesis, possibly related to chronic inflammation, induction of PGE(2), disruption of cell kinetics and induction of inflammatory cytokines...
  12. ncbi COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis
    Alfred S L Cheng
    Institute of Digestive Disease and Li Ka Shing Institute of Health Sciences, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China
    Biochem Biophys Res Commun 374:175-80. 2008
    ..Over-expression of HBx and COX-2 may provide a selective clonal advantage for preneoplastic or neoplastic hepatocytes and contribute to the initiation and progression of HCC...
  13. ncbi Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis
    Hai Feng
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
    J Clin Invest 121:3159-75. 2011
    ..Our results reveal a direct AR transcriptional target, CCRK, that promotes hepatocarcinogenesis through the upregulation of β-catenin/TCF signaling...
  14. ncbi RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma
    Alfred S L Cheng
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong
    Cancer Lett 253:43-52. 2007
    ..These results suggest that RNA interference-mediated HBx suppression exerts potent anti-proliferative and chemosensitizing effects in human HCC...
  15. ncbi Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells
    Ya C Wu
    School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
    PLoS ONE 7:e37572. 2012
    ..Collectively, we demonstrate that H(2)S inhibits colon epithelial cell proliferation and induces protective autophagy via the AMPK pathway...
  16. ncbi NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors
    Vivian Y Shin
    Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
    Carcinogenesis 32:240-5. 2011
    ..Perhaps this study may shed light on the development of anticancer drugs to improve the chemosensitivity in smokers...
  17. ncbi Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro
    Jun Yu
    Institute of Digestive Disease and Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, Hong Kong, China
    Hepatology 51:2008-19. 2010
    ..PPARgamma suppresses tumor cell growth through reducing cell proliferation and inducing G(2)/M phase arrest, apoptosis, and up-regulating growth differentiation factor-15. Thus, PPARgamma acts as a tumor-suppressor gene in the liver...
  18. ncbi Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer
    Shun X Ren
    School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong
    Cancer Res 72:6512-23. 2012
    ..Collectively, our findings show that LL-37 activates a GPCR-p53-Bax/Bak/Bcl-2 signaling cascade that triggers AIF/EndoG-mediated apoptosis in colon cancer cells...
  19. ncbi Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis
    Jun Yu
    Department of Medicine and Therapeutics, Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, NT, Hong Kong
    Gut 56:991-9. 2007
    ..However, it is not known whether overexpression of COX-2 in the liver is sufficient to promote activation or secretion of inflammatory factors leading to hepatitis...
  20. ncbi Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma
    Kin Mang Lau
    Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
    Acta Neuropathol 123:553-71. 2012
    ..Importantly, the results highlight the therapeutic potential of targeting HMGA1 in MB patients...
  21. ncbi Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2
    Daisy P F Tsang
    Institute of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China
    J Gastroenterol Hepatol 26:19-27. 2011
    ..Better understanding of the molecular basis of such regulations in various cancer types will help establish EZH2-mediated epigenetic silencing as a therapeutic target...
  22. ncbi Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant
    Meiyun Fan
    Medical Sciences, Indiana University School of Medicine, Bloomington, Indiana 47405, USA
    Cancer Res 66:11954-66. 2006
    ..Such knowledge of resistance-associated mechanisms could allow for identification of therapy targets and strategies for resensitization to these well-established antihormonal agents...
  23. ncbi Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer
    Benjamin A T Rodriguez
    Human Cancer Genetics Program, The Ohio State University, Columbus, OH 43210, USA
    Carcinogenesis 29:1459-65. 2008
    ..029) in cancer patients. These results suggest that hypermethylation of HOXB13 is a late event of breast tumorigenesis and a poor prognostic indicator of node-positive cancer patients...